8 K), although the increase of the Lactobacillaceae family bacteria caused by the combination treatment did not reach statistical significance compared with untreated Cyp2c70 KO mice ( Fig. 8 A–B).
← all excerpts
A Gly-β-muricholic acid and FGF15 combination therapy synergistically reduces "humanized" bile acid pool toxicity in cholestasis mice.
1
—
—